Beginning September 28, 2026, the AdventHealth Lab will use fungal next-generation sequencing (NGS) in place of routinely ordered fungal cultures. This update is designed to support faster fungal diagnosis and guide more timely antifungal management.
Effective October 5, 2026, we’re updating our Patient Service Center hours to make lab visits more convenient. With earlier hours and added weekend availability, we hope to Make It Easy to schedule lab appointments.
Hunter’s Creek Lab is closing effective October 3, 2026. Please visit us at our nearest location: Our team will be happy to continue to serving you. AdventHealth Kissimmee Outpatient Lab, 201 N Hilda St, Kissimmee, FL 34741
Effective July 16, 2026, the NGAL (Neutrophil Gelatinase-Associated Lipocalin), Urine (LAB0020) test was temporarily discontinued. Presently, there are concerns with NGAL, Urine quality control testing performance. Patients were not impacted. Nonetheless, out of an abundance of caution, we will not continue testing until this issue is resolved. The test will still be orderable in Epic; however, samples will be frozen until testing can resume. We will alert clinical teams when we are able to resume testing. We apologize for any inconvenience this may cause.
Beginning July 21, 2026, AdventHealth Orlando will implement the CDC-recommended reverse syphilis testing algorithm for patients older than 24 months. The DiaSorin LIAISON Treponema assay (LAB1197) will be used as the initial screening test, with reflex testing performed as indicated. Patients 24 months of age and younger will continue to be tested using the traditional syphilis algorithm (RPR LAB6791). This update aligns AdventHealth Orlando with current CDC laboratory recommendations, supports timely and accurate diagnosis of syphilis, and improves laboratory efficiency through automation.
To improve diagnostic accuracy and patient care, the Wet Prep Vaginal Test (LAB252) will be discontinued, June 30, 2026. Providers should transition to the Vaginal Pathogen DNA Panel (LAB4038), a PCR based assay that offers improved sensitivity and specificity.
AdventHealth Lab offers comprehensive testing to support the diagnostic evaluation of Alzheimer’s disease. These tests provide community providers with valuable insights to help guide patient care and clinical management.
The ThinPrep image-guided system used by AdventHealth Lab scans every cell and cell cluster, providing increased sensitivity and specificity over manually-reviewed pap slides. This innovative technology helps reduce false negatives as well as decreases unsatisfactory and ASCUS rates.
The ThinPrep image-guided system used by AdventHealth Lab scans every cell and cell cluster, providing increased sensitivity and specificity over manually-reviewed pap slides. This innovative technology helps reduce false negatives as well as decreases unsatisfactory and ASCUS rates.
WBC Differential Protocol - WBC Differentials will not be performed on specimens with WBC counts less than 0.31 x 103 /uL.